New antiviral therapies for hepatitis C virus infection, with cure rates exceeding 95%, should prompt transplant-community leaders to view HCV-positive organs as a valuable opportunity for transplant candidates with or without preexisting HCV infection.
No takes yet. Share an insight, caveat, or question.
Reese et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: